Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
21.50
0.00 (-0.02%)
Jan 12, 2026, 10:02 AM EST - Market open
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $2.11 billion as of January 12, 2026. Its market cap has increased by 115.92% in one year.
Market Cap
2.11B
Enterprise Value
2.06B
1-Year Change
115.92%
Ranking
Category
Stock Price
$21.50
Market Cap Chart
Since April 15, 2024, Avadel Pharmaceuticals's market cap has increased from $1.54B to $2.11B, an increase of 37.02%. That is a compound annual growth rate of 19.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.11B | -0.23% |
| Dec 31, 2025 | 2.12B | 108.86% |
| Dec 31, 2024 | 1.01B | -34.23% |
| Apr 15, 2024 | 1.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |